Aadi Bioscience Inc

NASDAQ:AADI 4:00:00 PM EDT

12.58

-0.04 (-0.32%)

7:15:32 PM EDT: $13.20 +0.62 (+4.93%)

Market Cap (Intraday)	306.88M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$4.65 Million
Adjusted EPS	-$0.71

See more estimates

10-Day MA	$12.71
50-Day MA	$12.84
200-Day MA	$13.39

See more pivots

Aadi Bioscience Inc Stock, NASDAQ:AADI

17383 Sunset Boulevard, Suite A250, Los Angeles, California 90272

United States of America

Phone: +1.424.473.8055

Number of Employees: 39

http://www.aadibio.com

Description

Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancers patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai on November 2007 and is headquartered in Los Angeles, CA.